Author Topic: (Abst.) Risk factors for reactivation of disease activity after stopping Tysabri  (Read 81 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9839
  • MS diagnosed 1980
  • Location: Pacific Northwest

From PubMed (December 22, 2019), "Risk factors for reactivation of clinical disease activity in multiple sclerosis after natalizumab cessation":

https://www.ncbi.nlm.nih.gov/pubmed/31864192
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics